Skip to content

Estimation of efficacy of Reduced form of Coenzyme Q10 (Ubiquinol) gummi on oral function in healthy people

Estimation of efficacy of Reduced form of Coenzyme Q10 (Ubiquinol) gummi on oral function in healthy people - Estimation of efficacy of Reduced form of Coenzyme Q10 (Ubiquinol) gummi on oral function in healthy people

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024406
Enrollment
50
Registered
2016-10-20
Start date
2016-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Reduced form of Coenzyme Q10 (Ubiquinol) gummi, 100mg/day, 8 weeks. Placebo gummi, 8 weeks.

Sponsors

Tsurumi University School of Dental Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects are healthy 20-65 years old person.

Exclusion criteria

Exclusion criteria: 1.under medication 2.take medicine and food that might impact the outcome measure 3.Patient of serious disease such as liver disease,renal disease,heart disease,cancer 4.Pregnant and women who wish to pregnant in this study period 5.Sjogren's syndrome patients 6.The person that the eating habits are extremely irregular, Person of shift work, Person of graveyard shift 7.The person indicating the allergic reaction to experimental diet 8.The person entry another clinical study which ongoing or within four weeks after other clinical study end or with the plan to participate in other clinical study 9.Doctor did not allow to entry to this study

Design outcomes

Primary

MeasureTime frame
CoQ10 concentration in saliva Amount of saliva secretion Anti-oxidative activity of saliva Oxidative stress in saliva RSST biting force These items will be determined at 0,8weeks after intake.

Countries

Japan

Contacts

Public ContactKenj Fujii

KANEKA CORPORATION QOL Division

Kenji.Fujii@kaneka.co.jp03-5574-8112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026